Strategic Partnerships Leverage Kimia Farma's established public company status and long-standing market presence to pursue co-branding, distribution alliances, and joint initiatives with healthcare providers, especially in remote regions highlighted by recent island health programs.

Expansion Opportunities Capitalize on their growth potential abroad and in Indonesia through expansion-friendly products, API and finished dose manufacturing collaborations, and import-export services, aligning with their international investment signals.

Public Sector Access Target government and state-linked healthcare projects by offering compliant, affordable pharmaceutical supply and testing services, leveraging their AKHLAK recognition and track record with nationalized health initiatives.

Medical Outreach Align with Kimia Farma’s patient-centric programs such as the Indonesia Healthy Island Floating Clinic to pilot mobile health units, vaccines, or essential medicines in remote areas, generating new sales channels and brand loyalty.

Risk & Compliance Proactively address reputational risk and quality assurance, offering robust narative and products to mitigate past controversies, while highlighting strong governance and quality controls to reassure buyers and partners.